Serial Number:
90420060
Mark:
SANGAMO THERAPEUTICS
Status:
Fifth Extension-Granted
Status Date:
08-09-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use Licensing of intellectual property rights Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
Mark Description:
N/A
Class:
Legal services
Type of Mark:
Trademark
Published for Opposition Date:
12-28-2021
Owner:
Mark Drawing Status:
4
Abandon Date:
N/A
Business Name:
2175 NORTH CALIFORNIA BOULEVARD
Correspondent Name:
